-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Immunosuppressants used in organ transplantation significantly increase the incidence of tumors, especially skin tumors
.
In a study conducted at the German center, the cumulative incidence of non-melanocytic skin cancer (NMSC) in kidney transplant recipients was 20.
immune infection
The results showed that the main risk factors for the development of skin tumors were the patient's age at the time of transplantation, light skin color, previous and current sun exposure, and the type and timing of immunosuppressive therapy
.
Squamous cell carcinoma (SCC) is the most common skin tumor in immunosuppressed patients
Taken together, the findings of this study suggest that cutaneous squamous cell carcinoma increases morbidity and mortality in transplant recipients and is therefore one of the major oncological challenges for this patient population
.
The structured concept of multidisciplinary care enables risk-adaptive treatment
Original source:
Claas Ulrich, et al.
Skin changes following organ transplantation: an interdisciplinary challengeleave a message here